Skip to main content
UniHealth

Doctor search

Daniel F Becker, MD

Psychiatry · San Francisco

NPI 1841256856

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
9
1 carrier
Office
1
Since medical school
44 years
University of Wisconsin School of Medicine, 1982

Offices

1 location · University of California San Francisco · 1,780 clinicians in this group

Looking this up.

Plans that list them

9 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Becker’s office at (415) 476-4029 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence G62593 · Current

Licensed to practise in California · since 1988 · expires 2027-06-30 · University of Wisconsin Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Psychiatry and Neurology - Addiction Psychiatry
  • American Board of Psychiatry and Neurology - Psychiatry

Drugs they prescribed that Part D paid

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their 21 Part D prescriptions in 2017. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

Money from drug and device companies

$110 in 2025

Industry payments by year
202514None$110
202411None$69
202312None$470
201911None$106

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
StrykerFlowtriever$110
4 payments
  • Meals for Flowtriever · 2025-11-08 · $19
  • Meals for Flowtriever · 2025-10-01 · $39
  • Meals for Flowtriever · 2025-09-18 · $15
  • Meals for Clottriever Bold Catheter · 2025-08-27 · $36
See all 4 published payments
Every published payment
StrykerMeals · 2025-11-08Flowtriever$19
StrykerMeals · 2025-10-01Flowtriever$39
StrykerMeals · 2025-09-18Flowtriever$15
StrykerMeals · 2025-08-27Clottriever Bold Catheter$36
See earlier years (2024, 2023, 2019)

2024: $69

Payments by company in 2024
TG TherapeuticsBriumvi$69
1 payment
  • Meals for Briumvi · 2024-05-29 · $69

2023: $470

Payments by company in 2023
Tg TherapeuticsBriumvi$470
2 payments
  • Meals for Briumvi · 2023-04-27 · $118
  • Travel for Briumvi · 2023-04-27 · $353

2019: $106

Payments by company in 2019
Teva Pharmaceuticals USACinqair$106
1 payment
  • Meals for Cinqair · 2019-04-20 · $106

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
GENZYME CORPORATION · A Prospective, Multicenter, Observational, Post-Authorization Safety Study (Pass) To Evaluate the Long Term Safety Profile of Lemtrada (Alemtuzumab) Treatment in Patients With Relapsing Forms of Multiple Sclerosis (Rms) · 2021Their institution$5,850

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
74.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1841256856
Licence
CA G62593California G62593: Current · expires 2027-06-30
Trained
University of Wisconsin School of Medicine, 1982 · 44 years ago
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Psychiatry (2084P0800X)
Mailing address
1 Baywood Avenue, Suite 7, San Mateo, CA, 94402
NPI first listed
2006-04-26
NPI last updated
2026-07-13

This is when the NPI record was last certified, not a medical board exam.